SOLICITATION NOTICE
65 -- RFI-Disinfectant_Port_Protectors - QSL RFI Vendor Response Worksheet
- Notice Date
- 6/9/2017
- Notice Type
- Presolicitation
- NAICS
- 339113
— Surgical Appliance and Supplies Manufacturing
- Contracting Office
- Defense Logistics Agency, DLA Acquisition Locations, DLA Troop Support - Medical, 700 Robbins Avenue, Philadelphia, Pennsylvania, 19111-5096, United States
- ZIP Code
- 19111-5096
- Solicitation Number
- RFI-MN-1703-23
- Point of Contact
- Mr. Mark Probus, Phone: 571-231-5451, Mr. Gregory Morrison, Phone: 571-231-5905
- E-Mail Address
-
mark.c.probus2.ctr@mail.mil, gregory.p.morrison.ctr@mail.mil
(mark.c.probus2.ctr@mail.mil, gregory.p.morrison.ctr@mail.mil)
- Small Business Set-Aside
- N/A
- Description
- The vendors’ responses shall include all detailed information requested in the RFI Vendor Response Worksheet and shall also include: (1) Company name and address; (2) Company POC (Name and Phone Number, Fax Number, and E-mail address); and (3) Commercial and Government Entity (CAGE) Code. Supporting documentations are required to be provided by the offeror as attachments to this RFI. The attached spreadsheet must be completely filled out and submitted timely along with all supporting material such as but not limited to Training Literature, FDA approved information, etc. REQUEST FOR INFORMATION (RFI) Disinfectant Port Protectors 1.0Introduction 1.1General. The purpose of this request is to obtain information from industry to support the government's intent to establish a Qualified Supplier List (QSL) for the standardization of Disinfectant Port Protectors. This RFI is an invitation to submit to the Defense Health Agency (DHA) Medical Logistics (MEDLOG) Division Medical Materiel Enterprise Standardization Office (MMESO) the following: technical information and all related supporting documentation for Disinfectant Port Protectors. This request is a market research effort undertaken by the government which will be used for information gathering purposes. The information received may be used for Acquisition Planning purposes and may help define future requirements for the subject item(s). This is not a request for quote or proposal. 1.2RFI Submission Package. Vendors must provide responses to this RFI via the RFI Vendor Response Worksheet. Complete answers and all supporting documentation must be provided with the vendor's response. Responses for each salient characteristic should be in the form of yes, no, or alternate proposal. Although explanatory comments may be provided for all responses, they are required for "no" responses. 2.0Scope Examples of items for this product line could include but are not limited to: Disinfectant Port Protectors designed to be attached to I.V. access points to provide disinfection and protection. 3.0Characteristics/Specification Feedback Requested: Respondents are requested to provide information concerning their Disinfectant Port Protectors regarding the following questions: 3.1Are your Disinfectant Port Protectors manufactured in a TAA compliant country? Please supply the country of origin. 3.2Are your Disinfectant Port Protectors FDA approved? What type of documentation would you provide to support that? 3.3Are your Disinfectant Port Protectors designed to attach around the female end of needle-free I.V. connectors? If so, how are they configured to facilitate the attachment (e.g. grooves to improve grip)? 3.4Are your Disinfectant Port Protectors designed for use on injection ports? 3.5Do you offer Disinfectant Port Protectors specifically designed to attach to the male end of needle-free IV connectors? If so, please provide part number(s). 3.6Do your Disinfectant Port Protectors provide a "visual identification" feature (e.g. color coded cap) to support medical facility port protection usage compliance? Please list any other type of "visual identification" feature available on your Disinfectant Port Protectors. 3.7What disinfecting agent(s) is utilized by your Disinfectant Port Protectors? 3.8How is the disinfecting agent(s) delivered to the I.V. port (e.g. medical-grade sponge, a non-particulate generating pad, foam disc, or other means of delivery)? Is this method of delivery proprietary? 3.9List the microbes killed by the disinfecting agent(s) used in your Disinfectant Port Protectors. 3.10How long does it take for the disinfecting agent to achieve a 99.99% reduction or the minimum 4-log reduction of microbes your product(s) are designed to inactivate? Please provide documentation to support this claim. 3.11How long do your Disinfectant Port Protectors maintain 99.99% reduction or the minimum 4-log reduction of microbes your product(s) are designed to inactivate? 3.11.1Is this 99.99% microbe reduction due to the disinfecting agent actively killing microbes during this time? How long does the disinfecting agent remain active? 3.11.2Is this 99.99% microbe reduction maintained solely due to the port protector cap acting as a physical barrier to any new microbes accessing the I.V. port? 3.11.3During the time your Disinfectant Port Protector is actively in place, does the disinfecting agent continuously bathe the valve surface? 3.11.4When used appropriately, is it reasonable to expect some disinfecting agent left at the end of recommended application period? Please explain your answer. 3.12Do your Disinfectant Port Protectors come sterile or non-sterile, or both? 3.13What are the Units of Measure/Units of Issue available for procurement? 3.13.1Do your Disinfectant Port Protectors come in strips? How many Disinfectant Port Protectors per strip? 3.13.2Please list all forms of packaging available for your Disinfectant Port Protectors. 3.14What is the shelf life of your Disinfectant Port Protectors? 3.14.1Where is this information available? 3.15What product information is described on the product packaging? 3.16List design feature(s) that differentiate your Disinfectant Port Protector from an IV End Cap. 3.17List design feature(s) of your Disinfectant Port Protector that assist with its placement on IV port while wearing gloves. 3.18List design feature(s) that prevent your Disinfectant Port Protector from opening needleless connectors. 3.19List waste disposal procedure of your Disinfectant Port Protectors. 4.0Feedback Requested Please complete the attached RFI Vendor Response Worksheet with indicated information about your Disinfectant Port Protectors. 4.1Have your Disinfectant Port Protectors been subject to any recall(s)? If so, what corrective actions and/or product modifications have been made in response to the recall(s)? 4.2Do you have any emerging Disinfectant Port Protectors technology you would like to share? 4.3Please provide any additional information including relative topics outside of the specific information requested which you consider relevant. Any information provided in response to this RFI will be considered and treated as unrestricted information which can be used by the Government in any future planning or acquisitions. All information, comments, and suggestions may be incorporated into future acquisition documents, without identifying the source or obtaining prior approval from the source. 5.0Liability The Government shall not be responsible or liable for any costs incurred by any party in the preparation and submission of any response to this RFI. 6.0RFI Responses 6.1The vendors' responses shall include all detailed information requested in the RFI Vendor Response Worksheet and shall also include: (1) Company name and address; (2) Company POC (Name and Phone Number, Fax Number, and E-mail address); and (3) Commercial and Government Entity (CAGE) Code. 6.2Supporting documentations are required to be provided by the offeror as attachments to this RFI. The attached spreadsheet must be completely filled out and submitted timely along with all supporting material such as but not limited to Training Literature, FDA approved information, etc. Points of Contact (POCs): Mr. Mark Probus, MMESO North Team Leader, mark.c.probus2.ctr@mail.mil, 571-231-5451; and Mr. Gregory Morrison, MMESO North Clinical Analyst, gregory.p.morrison.ctr@mail.mil, 571-231-5905.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/DLA/J3/DSCP-M/RFI-MN-1703-23/listing.html)
- Place of Performance
- Address: Medical Materiel Enterprise Standardization Offices, Northern Regional Medical Command HQ, ATTN: ACSLA (MCAT-LA), Building 1221 2nd Floor, 9275 Doerr Road, Fort Belvoir, Virginia, 22060, United States
- Zip Code: 22060
- Zip Code: 22060
- Record
- SN04540138-W 20170611/170609235120-b998628785632dc200bbf84aca30e3ae (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |